Global Nonalcoholic Steatohepatitis Diagnostic Industry

2023-2029 Global Nonalcoholic Steatohepatitis Diagnostic Industry Research & Trends Analysis Report

Global Nonalcoholic Steatohepatitis Diagnostic Industry

2023-2029 Global Nonalcoholic Steatohepatitis Diagnostic Industry Research & Trends Analysis Report


The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to Latest Study , the global market for Nonalcoholic Steatohepatitis Diagnostic should grow from US$ 1423.5 million in 2023 to US$ 2043.5 million by 2030, with a CAGR of 5.3% for the period of 2024-2030.

China Nonalcoholic Steatohepatitis Diagnostic market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Nonalcoholic Steatohepatitis Diagnostic market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Serum Biomarkers segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Pharma & CRO Industry has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.

The global key manufacturers of Nonalcoholic Steatohepatitis Diagnostic include Echosens, Prometheus Laboratories, GENFIT SA, Siemens Medical Solutions USA, Inc., BioPredictive S.A.S, Quest Diagnostics Incorporated., Meridian Bioscience, Inc. and Laboratory Corporation of America Holdings, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is part of a group of conditions called nonalcoholic fatty liver disease.

This report aims to provide a comprehensive study of the global market for Nonalcoholic Steatohepatitis Diagnostic. Report Highlights:

(1) Global Nonalcoholic Steatohepatitis Diagnostic market size (value), history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Nonalcoholic Steatohepatitis Diagnostic market competitive situation, revenue and market share, from 2019 to 2024.

(3) China Nonalcoholic Steatohepatitis Diagnostic market competitive situation, revenue and market share, from 2019 to 2024.

(4) Global Nonalcoholic Steatohepatitis Diagnostic segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Nonalcoholic Steatohepatitis Diagnostic segment by type and by application and regional segment by type and by application.

(6) Nonalcoholic Steatohepatitis Diagnostic industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Serum Biomarkers

Hepatic Fibrosis Biomarkers

Oxidative Stress Biomarkers

Apoptosis Biomarkers

Others

Market segment by application, can be divided into

Pharma & CRO Industry

Hospitals

Academic Research Institutes

Others

Market segment by players, this report covers

Echosens

Prometheus Laboratories

GENFIT SA

Siemens Medical Solutions USA, Inc.

BioPredictive S.A.S

Quest Diagnostics Incorporated.

Meridian Bioscience, Inc.

Laboratory Corporation of America Holdings

1 Market Overview

1.1 Product Overview and Scope of Nonalcoholic Steatohepatitis Diagnostic

1.2 Global Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast

1.3 China Nonalcoholic Steatohepatitis Diagnostic Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Nonalcoholic Steatohepatitis Diagnostic Share in Global Market, 2019-2030

1.4.2 Nonalcoholic Steatohepatitis Diagnostic Market Size: China VS Global, 2019-2030

1.5 Nonalcoholic Steatohepatitis Diagnostic Market Dynamics

1.5.1 Nonalcoholic Steatohepatitis Diagnostic Market Drivers

1.5.2 Nonalcoholic Steatohepatitis Diagnostic Market Restraints

1.5.3 Nonalcoholic Steatohepatitis Diagnostic Industry Trends

1.5.4 Nonalcoholic Steatohepatitis Diagnostic Industry Policy

2 Global Competitive Situation by Company

2.1 Global Nonalcoholic Steatohepatitis Diagnostic Revenue by Company (2019-2024)

2.2 Global Nonalcoholic Steatohepatitis Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Nonalcoholic Steatohepatitis Diagnostic Concentration Ratio

2.4 Global Nonalcoholic Steatohepatitis Diagnostic Mergers & Acquisitions, Expansion Plans

2.5 Global Nonalcoholic Steatohepatitis Diagnostic Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Nonalcoholic Steatohepatitis Diagnostic Revenue by Company (2019-2024)

3.2 China Nonalcoholic Steatohepatitis Diagnostic Nonalcoholic Steatohepatitis Diagnostic Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Nonalcoholic Steatohepatitis Diagnostic, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)

4 Industry Chain Analysis

4.1 Nonalcoholic Steatohepatitis Diagnostic Industry Chain

4.2 Nonalcoholic Steatohepatitis Diagnostic Upstream Analysis

4.3 Nonalcoholic Steatohepatitis Diagnostic Midstream Analysis

4.4 Nonalcoholic Steatohepatitis Diagnostic Downstream Analysis

5 Sights by Type

5.1 Nonalcoholic Steatohepatitis Diagnostic Classification

5.1.1 Serum Biomarkers

5.1.2 Hepatic Fibrosis Biomarkers

5.1.3 Oxidative Stress Biomarkers

5.1.4 Apoptosis Biomarkers

5.1.5 Others

5.2 By Type, Global Nonalcoholic Steatohepatitis Diagnostic Market Size & CAGR, 2019 VS 2023 VS 2030

5.3 By Type, Global Nonalcoholic Steatohepatitis Diagnostic Revenue, 2019-2030

6 Sights by Application

6.1 Nonalcoholic Steatohepatitis Diagnostic Segment by Application

6.1.1 Pharma & CRO Industry

6.1.2 Hospitals

6.1.3 Academic Research Institutes

6.1.4 Others

6.2 By Application, Global Nonalcoholic Steatohepatitis Diagnostic Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Application, Global Nonalcoholic Steatohepatitis Diagnostic Revenue, 2019-2030

7 Sales Sights by Region

7.1 By Region, Global Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019 VS 2023 VS 2030

7.2 By Region, Global Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

7.3 North America

7.3.1 North America Nonalcoholic Steatohepatitis Diagnostic Market Size & Forecasts, 2019-2030

7.3.2 By Country, North America Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share

7.4 Europe

7.4.1 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size & Forecasts, 2019-2030

7.4.2 By Country, Europe Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size & Forecasts, 2019-2030

7.5.2 By Country/Region, Asia Pacific Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share

7.6 South America

7.6.1 South America Nonalcoholic Steatohepatitis Diagnostic Market Size & Forecasts, 2019-2030

7.6.2 By Country, South America Nonalcoholic Steatohepatitis Diagnostic Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Nonalcoholic Steatohepatitis Diagnostic Market Size & CAGR，2019 VS 2023 VS 2030

8.2 By Country, Global Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.3 U.S.

8.3.1 U.S. Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.3.2 By Company, U.S. Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.3.3 By Type, U.S. Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.3.4 By Application, U.S. Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.4 Europe

8.4.1 Europe Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.4.2 By Company, Europe Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.4.3 By Type, Europe Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.4.4 By Application, Europe Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.5 China

8.5.1 China Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.5.2 By Company, China Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.5.3 By Type, China Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.5.4 By Application, China Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.6 Japan

8.6.1 Japan Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.6.2 By Company, Japan Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.6.3 By Type, Japan Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.6.4 By Application, Japan Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.7 South Korea

8.7.1 South Korea Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.7.2 By Company, South Korea Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.7.3 By Type, South Korea Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.7.4 By Application, South Korea Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.8 Southeast Asia

8.8.1 Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.8.2 By Company, Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.8.3 By Type, Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.8.4 By Application, Southeast Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.9 India

8.9.1 India Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.9.2 By Company, India Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.9.3 By Type, India Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.9.4 By Application, India Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.10 Middle East & Asia

8.10.1 Middle East & Asia Nonalcoholic Steatohepatitis Diagnostic Market Size, 2019-2030

8.10.2 By Company, Middle East & Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2019-2024

8.10.3 By Type, Middle East & Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

8.10.4 By Application, Middle East & Asia Nonalcoholic Steatohepatitis Diagnostic Revenue Market Share, 2023 VS 2030

9 Global Manufacturers Profile

9.1 Echosens

9.1.1 Echosens Company Information, Head Office, Market Area and Industry Position

9.1.2 Echosens Company Profile and Main Business

9.1.3 Echosens Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.1.4 Echosens Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.1.5 Echosens Recent Developments

9.2 Prometheus Laboratories

9.2.1 Prometheus Laboratories Company Information, Head Office, Market Area and Industry Position

9.2.2 Prometheus Laboratories Company Profile and Main Business

9.2.3 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.2.4 Prometheus Laboratories Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.2.5 Prometheus Laboratories Recent Developments

9.3 GENFIT SA

9.3.1 GENFIT SA Company Information, Head Office, Market Area and Industry Position

9.3.2 GENFIT SA Company Profile and Main Business

9.3.3 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.3.4 GENFIT SA Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.3.5 GENFIT SA Recent Developments

9.4 Siemens Medical Solutions USA, Inc.

9.4.1 Siemens Medical Solutions USA, Inc. Company Information, Head Office, Market Area and Industry Position

9.4.2 Siemens Medical Solutions USA, Inc. Company Profile and Main Business

9.4.3 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.4.4 Siemens Medical Solutions USA, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.4.5 Siemens Medical Solutions USA, Inc. Recent Developments

9.5 BioPredictive S.A.S

9.5.1 BioPredictive S.A.S Company Information, Head Office, Market Area and Industry Position

9.5.2 BioPredictive S.A.S Company Profile and Main Business

9.5.3 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.5.4 BioPredictive S.A.S Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.5.5 BioPredictive S.A.S Recent Developments

9.6 Quest Diagnostics Incorporated.

9.6.1 Quest Diagnostics Incorporated. Company Information, Head Office, Market Area and Industry Position

9.6.2 Quest Diagnostics Incorporated. Company Profile and Main Business

9.6.3 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.6.4 Quest Diagnostics Incorporated. Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.6.5 Quest Diagnostics Incorporated. Recent Developments

9.7 Meridian Bioscience, Inc.

9.7.1 Meridian Bioscience, Inc. Company Information, Head Office, Market Area and Industry Position

9.7.2 Meridian Bioscience, Inc. Company Profile and Main Business

9.7.3 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.7.4 Meridian Bioscience, Inc. Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.7.5 Meridian Bioscience, Inc. Recent Developments

9.8 Laboratory Corporation of America Holdings

9.8.1 Laboratory Corporation of America Holdings Company Information, Head Office, Market Area and Industry Position

9.8.2 Laboratory Corporation of America Holdings Company Profile and Main Business

9.8.3 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Models, Specifications and Application

9.8.4 Laboratory Corporation of America Holdings Nonalcoholic Steatohepatitis Diagnostic Revenue and Gross Margin, 2019-2024

9.8.5 Laboratory Corporation of America Holdings Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Nonalcoholic Steatohepatitis Diagnostic Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Nonalcoholic Steatohepatitis Diagnostic Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What is the anticipated growth rate for the Nonalcoholic Steatohepatitis Diagnostic Market?
During the projected year from 2025 to 2030, the Nonalcoholic Steatohepatitis Diagnostic Market is expected to grow at a CAGR of xx%.
Where does the Nonalcoholic Steatohepatitis Diagnostic Industry stands in terms of scaling end-use implementations?
According to the Nonalcoholic Steatohepatitis Diagnostic Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
What makes the latest Nonalcoholic Steatohepatitis Diagnostic Market study unique?
The latest version of the Nonalcoholic Steatohepatitis Diagnostic Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.